The European health regulator said on Friday it has started a review of anti hair-loss drugs, including Merck's Propecia, ...

Vice President Kamala Harris allies in the business community are trying to give her a boost over Donald Trump.

A phase 2/3 non-inferiority study compared de-escalation strategies to standard chemoradiation in patients with human ...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a ...

U.S. stocks were lower after the close on Thursday, as losses in the Consumer Goods, Basic Materials and Healthcare sectors ...

GSI Exim America signed a 10-year, 5,205-square-foot lease at BXP’s 7 Times Square for new space on part of the 38th floor.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, ...

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...

Merck (MRK) is one of the worst-performing stocks in the Dow Jones Industrial Average (DJIA) on Thursday. The US government ...

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally, the rising prevalence of diabetes and ...

Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...

The TAfricInvest and The Health Finance Coalition (HFC) today announced the final close of the pan-African Transform Health Fund (THF), an innovative blended-finance fund that aims to bolster ...